Specific laws and regulations for CBD are lagging far behind the evolution of the market, meaning CBD is now potentially the largest CPG product in Europe which is, in the majority, sold under legally ‘grey’ conditions. This situation is evolving fast, with new laws,...

The African medical cannabis and industrial hemp industries have seen significant growth and development over the course of 2021 and 2022. Countries such as South Africa, Lesotho, Zimbabwe, Uganda and Malawi have seen an increase in licence issuance, exports and inv...

Prohibition Partners estimates that, in 2022, the global sales of CBD, medical and adult-use cannabis amounted to US$45 billion and could be worth more than US$101 billion by 2026. Cannabis liberalisation is accelerating, with an increasing number of States and...

Thailand became the first country in Asia to decriminalise cannabis by removing the plant from its list of narcotics in June 2022. At this point, the Thai government endorsed the cultivation of cannabis; in private households, for medical purposes, and as an ingredie...

In this report, Prohibition Partners and Teera Group explore the regulations and market developments in the most populous continent in the world. The Asian Cannabis Report: 2nd Edition uncovers unique, country-specific challenges across Asia for cannabis, which have ...

The North American Cannabis Report: 3rd Edition provides the latest information and analysis on the development of the nascent cannabis markets across North America. Included in the report are deep dives into all key sectors and geographic regions in the North Americ...

The European Cannabis Report: 7th Edition provides the latest information and analysis on the development of the nascent cannabis markets across Europe. Included in the report are deep dives into all key sectors and geographic regions in the European cannabis industr...

We are currently living in an era marking the end of prohibition on cannabis. The global cannabis industry is heading into a period marked by widespread legalisation, innovation and considerable economic growth. After a tough year for cannabis in 2020, this yea...

Hemp manufacturing is re-emerging as a global industry, having historically been a major traditional industry in many parts of the world. The factors driving this re-emergence are many, and include various commercial and ecological considerations. The fastest growing...

The Impact Series is a series of five reports that analyse how cannabis is disrupting more mainstream and traditional industries, such as food, drinks, beauty, construction and manufacturing, amongst others. The Impact Series: Industrial Hemp A new, never-befo...

Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. However, regulations are constantly shifting. This report has been compiled to assist interested parties in understanding the market for the me...

The emerging extraction industry is proving to be one of the most active areas of innovation and growth in the cannabis industry. The Extraction Report takes a detailed look at this rapidly-growing and diversifying industry, analysing methods of extraction, the types...

This report takes an in-depth look at the progress of cannabis legalisation across Europe, the trade flows on the continent, the business opportunities, the medical products on the market and the patients who use them. We also consider how COVID-19 has affected the m...

Disrupting Petcare provides an overview of some of the key developments taking place in the emerging CBD pet supplement market. It explores the regulatory developments occurring in key markets, and looks into how much the market could be worth in the coming years. ...

*An updated version of this report - The North American Cannabis Report: 3rd Edition - has now been released. Click here for more information and to download. In 2020, the US saw further states legalising adult-use cannabis, Canada rolling out innovative Cannabis...

Germany is set to become one of the largest single markets for cannabis and CBD anywhere in the world. Despite the fact that millions of Germans are using CBD and cannabis, relatively little is currently known about these consumers. In this report we highlight ...

Cannabis has been present in Latin American countries for centuries. The Latin America and Caribbean Cannabis Report investigates pioneering legalisation from Colombia and Uruguay, joined in some degree by Argentina, Brazil, Chile, Ecuador, Paraguay, Peru, Jamaica, T...

CBD is a vast and complex subject area that touches on all aspects of the cannabis market – medical, pharmaceutical, recreational and packaged consumer products. Within this report, CBD – A Supply Overview, Prohibition Partners examines legislation, cultivation, extr...

The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of entry has been complicated by the historic scheduling of cannabis as a schedule 1 narcotic. However, pharmaceutical cannabis produ...

CBD has become one of the biggest disruptors of mainstream industries over the last decade, impacting sectors from pharma to food and wellness to cosmetics. Already a multibillion dollar opportunity globally, the market is expanding at an unprecedented rate but many ...